NCT00242476

Brief Summary

This study will assess the effectiveness of an investigational drug in elderly subjects with low vitamin D levels.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Sep 2005

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2005

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 18, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 20, 2005

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2006

Completed
Last Updated

May 14, 2015

Status Verified

May 1, 2015

Enrollment Period

10 months

First QC Date

October 18, 2005

Last Update Submit

May 13, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Mediolateral body sway at 16 weeks.

    at 16 weeks

Secondary Outcomes (1)

  • Functional status assessed using the Short Physical Performance Battery Test determined at 16 weeks. General safety and tolerability at 16 weeks.

    at 16 weeks

Interventions

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Man or a woman 70 years old or older in general good health

You may not qualify if:

  • Having any form of neurological impairments that may impair motor function.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lips P, Binkley N, Pfeifer M, Recker R, Samanta S, Cohn DA, Chandler J, Rosenberg E, Papanicolaou DA. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr. 2010 Apr;91(4):985-91. doi: 10.3945/ajcn.2009.28113. Epub 2010 Feb 3.

MeSH Terms

Conditions

Vitamin D Deficiency

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Medical Monitor

    Merck Sharp & Dohme LLC

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2005

First Posted

October 20, 2005

Study Start

September 1, 2005

Primary Completion

July 1, 2006

Study Completion

July 1, 2006

Last Updated

May 14, 2015

Record last verified: 2015-05